117 related articles for article (PubMed ID: 10791909)
1. The p41 fragment story.
Turk D; Guncar G; Turk V
IUBMB Life; 1999 Jul; 48(1):7-12. PubMed ID: 10791909
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.
Guncar G; Pungercic G; Klemencic I; Turk V; Turk D
EMBO J; 1999 Feb; 18(4):793-803. PubMed ID: 10022822
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.
Mihelic M; Dobersek A; Guncar G; Turk D
J Biol Chem; 2008 May; 283(21):14453-60. PubMed ID: 18362148
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
Bevec T; Stoka V; Pungercic G; Dolenc I; Turk V
J Exp Med; 1996 Apr; 183(4):1331-8. PubMed ID: 8666891
[TBL] [Abstract][Full Text] [Related]
5. Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-1 domain.
Lenarcic B; Ritonja A; Strukelj B; Turk B; Turk V
J Biol Chem; 1997 May; 272(21):13899-903. PubMed ID: 9153250
[TBL] [Abstract][Full Text] [Related]
6. Purification of the complex of cathepsin L and the MHC class II-associated invariant chain fragment from human kidney.
Ogrinc T; Dolenc I; Ritonja A; Turk V
FEBS Lett; 1993 Dec; 336(3):555-9. PubMed ID: 8282126
[TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin type-I-like domains in invariant chain fusion proteins mediate resistance to cathepsin L digestion.
Hitzel C; Kanzler H; König A; Kummer MP; Brix K; Herzog V; Koch N
FEBS Lett; 2000 Nov; 485(1):67-70. PubMed ID: 11086167
[TBL] [Abstract][Full Text] [Related]
8. The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators.
Somoza JR; Palmer JT; Ho JD
J Mol Biol; 2002 Sep; 322(3):559-68. PubMed ID: 12225749
[TBL] [Abstract][Full Text] [Related]
9. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
Fineschi B; Sakaguchi K; Appella E; Miller J
J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical localisation of cathepsin S, cathepsin L and MHC class II-associated p41 isoform of invariant chain in human lymph node tissue.
Zavasnik-Bergant V; Sekirnik A; Golouh R; Turk V; Kos J
Biol Chem; 2001 May; 382(5):799-804. PubMed ID: 11517933
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and NMR structure of p41icf, a potent inhibitor of human cathepsin L.
Chiva C; Barthe P; Codina A; Gairí M; Molina F; Granier C; Pugnière M; Inui T; Nishio H; Nishiuchi Y; Kimura T; Sakakibara S; Albericio F; Giralt E
J Am Chem Soc; 2003 Feb; 125(6):1508-17. PubMed ID: 12568610
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes.
Zavasnik-Bergant V; Schweiger A; Bevec T; Golouh R; Turk V; Kos J
Immunology; 2004 Jul; 112(3):378-85. PubMed ID: 15196205
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the parasite protease inhibitor chagasin in complex with a host target cysteine protease.
Ljunggren A; Redzynia I; Alvarez-Fernandez M; Abrahamson M; Mort JS; Krupa JC; Jaskolski M; Bujacz G
J Mol Biol; 2007 Aug; 371(1):137-53. PubMed ID: 17561110
[TBL] [Abstract][Full Text] [Related]
14. Individual recombinant thyroglobulin type-1 domains are substrates for lysosomal cysteine proteinases.
Pungercic G; Dolenc I; Dolinar M; Bevec T; Jenko S; Kolaric S; Turk V
Biol Chem; 2002 Nov; 383(11):1809-12. PubMed ID: 12530546
[TBL] [Abstract][Full Text] [Related]
15. The SEP domain of p47 acts as a reversible competitive inhibitor of cathepsin L.
Soukenik M; Diehl A; Leidert M; Sievert V; Büssow K; Leitner D; Labudde D; Ball LJ; Lechner A; Nägler DK; Oschkinat H
FEBS Lett; 2004 Oct; 576(3):358-62. PubMed ID: 15498563
[TBL] [Abstract][Full Text] [Related]
16. The p41 isoform of invariant chain is a chaperone for cathepsin L.
Lennon-Duménil AM; Roberts RA; Valentijn K; Driessen C; Overkleeft HS; Erickson A; Peters PJ; Bikoff E; Ploegh HL; Wolf Bryant P
EMBO J; 2001 Aug; 20(15):4055-64. PubMed ID: 11483509
[TBL] [Abstract][Full Text] [Related]
17. Exogenous Thyropin from p41 Invariant Chain Diminishes Cysteine Protease Activity and Affects IL-12 Secretion during Maturation of Human Dendritic Cells.
Zavašnik-Bergant T; Bergant Marušič M
PLoS One; 2016; 11(3):e0150815. PubMed ID: 26960148
[TBL] [Abstract][Full Text] [Related]
18. Two decades of thyroglobulin type-1 domain research.
Mihelic M; Turk D
Biol Chem; 2007 Nov; 388(11):1123-30. PubMed ID: 17976004
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal cysteine proteases: facts and opportunities.
Turk V; Turk B; Turk D
EMBO J; 2001 Sep; 20(17):4629-33. PubMed ID: 11532926
[TBL] [Abstract][Full Text] [Related]
20. Amino acid sequences of the human kidney cathepsins H and L.
Ritonja A; Popović T; Kotnik M; Machleidt W; Turk V
FEBS Lett; 1988 Feb; 228(2):341-5. PubMed ID: 3342889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
